172 related articles for article (PubMed ID: 23857910)
1. Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.
Park JH; Lee DW; Park KS
Asia Pac Psychiatry; 2014 Mar; 6(1):38-45. PubMed ID: 23857910
[TBL] [Abstract][Full Text] [Related]
2. Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease . a case-control study.
Snaedal J; Kristinsson J; Gunnarsdóttir S; Olafsdóttir ; Baldvinsson M; Jóhannesson T
Dement Geriatr Cogn Disord; 1998; 9(5):239-42. PubMed ID: 9701674
[TBL] [Abstract][Full Text] [Related]
3. Excess of serum copper not related to ceruloplasmin in Alzheimer disease.
Squitti R; Pasqualetti P; Dal Forno G; Moffa F; Cassetta E; Lupoi D; Vernieri F; Rossi L; Baldassini M; Rossini PM
Neurology; 2005 Mar; 64(6):1040-6. PubMed ID: 15781823
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease.
Squitti R; Simonelli I; Ventriglia M; Siotto M; Pasqualetti P; Rembach A; Doecke J; Bush AI
J Alzheimers Dis; 2014; 38(4):809-22. PubMed ID: 24072069
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
Rembach A; Doecke JD; Roberts BR; Watt AD; Faux NG; Volitakis I; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Wilson W; Ellis KA; Martins RN; Rowe CC; Villemagne VL; Ames D; Masters CL; AIBL research group ; Bush AI
J Alzheimers Dis; 2013; 34(1):171-82. PubMed ID: 23168449
[TBL] [Abstract][Full Text] [Related]
6. Free copper and resting temporal EEG rhythms correlate across healthy, mild cognitive impairment, and Alzheimer's disease subjects.
Babiloni C; Squitti R; Del Percio C; Cassetta E; Ventriglia MC; Ferreri F; Tombini M; Frisoni G; Binetti G; Gurzi M; Salinari S; Zappasodi F; Rossini PM
Clin Neurophysiol; 2007 Jun; 118(6):1244-60. PubMed ID: 17462944
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.
Arnal N; Cristalli DO; de Alaniz MJ; Marra CA
Brain Res; 2010 Mar; 1319():118-30. PubMed ID: 20026314
[TBL] [Abstract][Full Text] [Related]
8. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.
Squitti R; Barbati G; Rossi L; Ventriglia M; Dal Forno G; Cesaretti S; Moffa F; Caridi I; Cassetta E; Pasqualetti P; Calabrese L; Lupoi D; Rossini PM
Neurology; 2006 Jul; 67(1):76-82. PubMed ID: 16832081
[TBL] [Abstract][Full Text] [Related]
9. Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
Capo CR; Arciello M; Squitti R; Cassetta E; Rossini PM; Calabrese L; Rossi L
Biometals; 2008 Jun; 21(3):367-72. PubMed ID: 18060472
[TBL] [Abstract][Full Text] [Related]
10. Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
Siotto M; Simonelli I; Pasqualetti P; Mariani S; Caprara D; Bucossi S; Ventriglia M; Molinario R; Antenucci M; Rongioletti M; Rossini PM; Squitti R
J Alzheimers Dis; 2016; 50(4):1181-9. PubMed ID: 26836154
[TBL] [Abstract][Full Text] [Related]
11. Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study.
Squitti R; Simonelli I; Cassetta E; Lupoi D; Rongioletti M; Ventriglia M; Siotto M
Curr Alzheimer Res; 2017; 14(12):1318-1326. PubMed ID: 28669331
[TBL] [Abstract][Full Text] [Related]
12. Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals.
Squitti R; Ghidoni R; Scrascia F; Benussi L; Panetta V; Pasqualetti P; Moffa F; Bernardini S; Ventriglia M; Binetti G; Rossini PM
J Alzheimers Dis; 2011; 23(2):239-48. PubMed ID: 20930297
[TBL] [Abstract][Full Text] [Related]
13. Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease.
Squitti R; Ghidoni R; Siotto M; Ventriglia M; Benussi L; Paterlini A; Magri M; Binetti G; Cassetta E; Caprara D; Vernieri F; Rossini PM; Pasqualetti P
Ann Neurol; 2014 Apr; 75(4):574-80. PubMed ID: 24623259
[TBL] [Abstract][Full Text] [Related]
14. Copper levels in patients with rheumatoid arthritis.
Strecker D; Mierzecki A; Radomska K
Ann Agric Environ Med; 2013; 20(2):312-6. PubMed ID: 23772583
[TBL] [Abstract][Full Text] [Related]
15. An observational study on the influence of the APOE-epsilon4 allele on the correlation between 'free' copper toxicosis and EEG activity in Alzheimer disease.
Zappasodi F; Salustri C; Babiloni C; Cassetta E; Del Percio C; Ercolani M; Rossini PM; Squitti R
Brain Res; 2008 Jun; 1215():183-9. PubMed ID: 18486114
[TBL] [Abstract][Full Text] [Related]
16. Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer's disease cases and normal controls.
Pavlik V; Massman P; Barber R; Doody R
J Alzheimers Dis; 2013; 34(2):449-56. PubMed ID: 23241558
[TBL] [Abstract][Full Text] [Related]
17. Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease.
Squitti R; Quattrocchi CC; Salustri C; Rossini PM
Prion; 2008; 2(1):23-7. PubMed ID: 19164917
[TBL] [Abstract][Full Text] [Related]
18. Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD.
Squitti R
J Trace Elem Med Biol; 2014 Oct; 28(4):482-5. PubMed ID: 25066791
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).
Sparks DL; Petanceska S; Sabbagh M; Connor D; Soares H; Adler C; Lopez J; Ziolkowski C; Lochhead J; Browne P
Curr Alzheimer Res; 2005 Dec; 2(5):527-39. PubMed ID: 16375656
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
Squitti R; Bressi F; Pasqualetti P; Bonomini C; Ghidoni R; Binetti G; Cassetta E; Moffa F; Ventriglia M; Vernieri F; Rossini PM
Neurology; 2009 Jan; 72(1):50-5. PubMed ID: 19122030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
